Ads
    Related paper
  1. BIOMARKERS OF CARDIOVASCULAR RISK IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
  2. Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease
  3. CHANGES IN LIPIDS IN PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE STAGE OF DECOMPENSATION
  4. Markers of atherosclerotic risk in patients with non-alcoholic fatty liver disease: A preliminary study
  5. GEOMETRICAL MODEL OF HEART AT PATIENTS WITH NOT ALCOHOLIC FATTY ALCOHOLIC DISEASE OF THE LIVER
  6. FEATURES OF ULTRASONIC PICTURE GEPATOBILIARNA OF SYSTEM AND PANCREAS AT PATIENTS WITH NOT ALCOHOLIC FATTY ALCOHOLIC DISEASE OF THE LIVER
  7. ESTIMATION OF LIPID PROFILE AND GLYCEMIC STATUS AND LIVER ENZYMES, AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
  8. Improvement of Diagnostic Algorithm in Patients With Alcoholic Fatty Liver Disease by Using Non-invasive Methods of Verification of Liver Steatosis and Fibrosis
  9. Prevalence of Non-Alcoholic Fatty Liver Disease in Patients with Parkinson Disease
  10. Prevalence of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetic patients in correlation with coronary artery disease